Table 1 Demographic and clinical data of the sample
From: A rapid screening tool for fatigue impact in multiple sclerosis
Subjects with MS n = 62 | Healthy controls n = 24 | p value | |
|---|---|---|---|
Age (mean, SD) | 52 ± 10.5 | 52 ± 14.0 | 0.59° |
Gender (F/M) | 29/33 (47/53%) | 13/11 (54/46%) | 0.54* |
EDSS (Me, IQR) | 6.5 (3–8.5) | - | |
Type MS (PP/RR/SP/NA) | 14/16/20/12 | - | |
VAS_1 (Me, IQR) | 63 (39–76) | 23 (5–60) | <0.0001* |
VAS_2 (Me, IQR) | 43 (18–73) | 3 (0–20) | <0.0001* |
VAS_3 (Me, IQR) | 60 (35–79) | 18 (3–51) | <0.0001* |
Fatigue Severity Scale (Me, IQR) | 48 (34–56) | 23 (15–32) | <0.0001* |
Modified Fatigue Impact Scale (Me, IQR) | 43 (57–29) | 24 (9–31) | <0.0001* |
Guy's NDS, subscale fatigue (Me, IQR) | 3 (1–3) | 0 (0–3) | 0.01* |